Three experts on HCM discuss the difficulty in making the diagnosis of HCM as it encompasses a range of diseases and how testing can help. Furthermore, they present novel potential targets for intervention and trial data of previous trials with cardiac myosin inhibitors and what the future holds on this topic.
This educational program consists of 3 presentations on hypertrophic cardiomyopathy.
What are the challenges in making the right diagnosis? - Perry Elliott, MD, PhD – London, UK
Understanding the etiology of HCM and pathways for intervention - Roberto Barriales Villa, MD, PhD - A Coruña, Spain
The Clinical Challenge of Managing a Patient with HCM - Iacopo Olivotto, MD – Florence, Italy
For questions regarding this activity, please contact us at info@pace-cme.org.
This activity has been designed to meet the educational needs of cardiologists as well as all other physicians, physician assistants, nurse practitioners, nurses, pharmacists, and healthcare providers involved in managing patients with hypertrophic cardiomyopathy.
This enduring activity is accredited by the European Board for Accreditation of Continuing Education for Health Professional (EBAC) for 44 minutes of effective education time.
Through an agreement between EBAC and the American Medical Association, physicians may convert EBAC External CME credits to AMA PRA Category 1 Credits™. Information on the process to convert EBAC credit to AMA credit can be found on the AMA website. Other health care professionals may obtain from the AMA a certificate of having participated in an activity eligible for conversion of credit to AMA PRA Category 1 Credit(s)™.
Today’s healthcare environment is constantly evolving and advances of medical science occur at an accelerating pace. CME/CE plays an important role in the clinical environment and is an essential element of physician training, learning, and improvement, thereby importantly contributing to optimal patient care. Since 2000, MEDCON’s mission is to deliver high quality within the world of medical education by creating forums like PACE-CME, organizing live meetings, and providing online education. We aim to stimulate the review, exchange, and assimilation of key scientific findings to improve patients’ health, to raise awareness of new science underlying various disease states, and to accelerate the translation of this information into clinical practice.
Supported by an unrestricted educational grant from Bristol-Myers Squibb.
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of PACE-cme.
Release Date:
Expiration Date:
